<code id='F496FE23B3'></code><style id='F496FE23B3'></style>
    • <acronym id='F496FE23B3'></acronym>
      <center id='F496FE23B3'><center id='F496FE23B3'><tfoot id='F496FE23B3'></tfoot></center><abbr id='F496FE23B3'><dir id='F496FE23B3'><tfoot id='F496FE23B3'></tfoot><noframes id='F496FE23B3'>

    • <optgroup id='F496FE23B3'><strike id='F496FE23B3'><sup id='F496FE23B3'></sup></strike><code id='F496FE23B3'></code></optgroup>
        1. <b id='F496FE23B3'><label id='F496FE23B3'><select id='F496FE23B3'><dt id='F496FE23B3'><span id='F496FE23B3'></span></dt></select></label></b><u id='F496FE23B3'></u>
          <i id='F496FE23B3'><strike id='F496FE23B3'><tt id='F496FE23B3'><pre id='F496FE23B3'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:comprehensive    Page View:9
          King Street Properties’ Pathway Devens campus. -- biotech coverage from STAT
          Pat Greenhouse/Globe Staff

          MORRISVILLE, N.C. — Ten minutes from the Raleigh airport, the future of biotech is under construction.

          On either side of a new stretch of four-lane highway sit two $1 billion biomanufacturing campuses, which will bring a combined 2.5 million square feet of research and development and advanced manufacturing space to a region that has become the No. 1 place where North America makes prescription drugs.

          advertisement

          One campus, called Pathway Triangle, is being built by a developer from Boston, King Street Properties. King Street — which has projects in Cambridge, Waltham, Allston, and Lexington — is building a similarly vast biomanufacturing campus in Devens. But these days it also sees a land of opportunity 700 miles to the south, in North Carolina.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more
          Longer MASH drug regimen improved liver, Akero study finds
          Longer MASH drug regimen improved liver, Akero study finds

          AdobeAkeroTherapeuticssaidMondaythatextendingtreatmentwithitsexperimentaldrugfortheliverdiseaseknown

          read more
          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more

          Fetal cell organoids grown from amniotic fluid, study finds

          AdobeAsafetusdevelops,itsbodyisbathedinamnioticfluid:awarm,saltysoupofnutrients,hormones,andantibodi